Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 845,566 shares were traded during trading, a decline of 36% from the previous session’s volume of 1,312,155 shares.The stock last traded at $58.69 and had previously closed at $58.80. Wall Street Analysts Forecast Growth A number of analysts […]
Related Keywords
United States , Leerink Partnrs , Benjamin Hickey , Jamie Christensen , Stifel Nicolaus , Mirati Therapeutics Company Profile , Nasdaq , Mirati Therapeutics Inc , Securities Exchange Commission , Scotiabank , Blackrock Inc , Vanguard Group Inc , Goldman Sachs Group Inc , Mirati Therapeutics , Get Free Report , Exchange Commission , Street Corp , Goldman Sachs Group , Sachs Group , Mirati Therapeutics Daily , Nasdaq Mrtx , Mrtx , Medical , Stocks , Technicals ,
comparemela.com © 2020. All Rights Reserved.